Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
2.100
-0.040 (-1.87%)
At close: May 15, 2026, 4:00 PM EDT
2.190
+0.090 (4.29%)
After-hours: May 15, 2026, 5:12 PM EDT
Aethlon Medical Employees
Aethlon Medical had 9 employees as of March 31, 2025. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
n/a
Profits / Employee
-$1,280,233
Market Cap
3.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 9 | -5 | -35.71% |
| Mar 31, 2024 | 14 | -1 | -6.67% |
| Mar 31, 2023 | 15 | 1 | 7.14% |
| Mar 31, 2022 | 14 | 4 | 40.00% |
| Mar 31, 2021 | 10 | 2 | 25.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Co-Diagnostics | 115 |
| Beyond Air | 61 |
| Nuwellis | 38 |
| enVVeno Medical | 33 |
| Catheter Precision | 17 |
| HeartSciences | 15 |
| Autonomix Medical | 11 |
| iTonic Holdings | 7 |
AEMD News
- 6 weeks ago - Aethlon Medical Transcript: Emerging Growth Conference 91 - Transcripts
- 7 weeks ago - Advancements in Novel Immunotherapeutics in The Oncology Battle - Newsfile Corp
- 7 weeks ago - Aethlon Medical advances to final cohort in AEMD-2022-06 trial - TheFly
- 7 weeks ago - Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - PRNewsWire
- 2 months ago - Aethlon Medical Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 2 months ago - Aethlon Medical to evaluate range of strategic opportunities - TheFly
- 2 months ago - Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities - PRNewsWire
- 2 months ago - Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th - GlobeNewsWire